UCK1 Human

Uridine-Cytidine Kinase 1 Human Recombinant
Shipped with Ice Packs
In Stock

Description

Biochemical Function and Substrate Specificity

UCK1 is a 277-amino-acid protein (31 kDa) encoded by the UCK1 gene on chromosome 9q34.13 . It phosphorylates uridine and cytidine using ATP or GTP as phosphate donors but does not act on deoxyribonucleosides or purine ribonucleosides . Key substrates include:

  • Uridine: Converted to UMP (primary substrate).

  • Cytidine: Converted to CMP.

  • Nucleoside analogs: 5-fluorouridine, 6-azauridine, and others, which are relevant in anticancer therapies .

Table 1: Catalytic Efficiency of UCK1 Compared to UCK2 and UCKL-1

EnzymeSubstratekcat/KMk_{cat}/K_M (s⁻¹·M⁻¹)Phosphate Donor
UCK1Uridine1.2 × 10⁴ATP/GTP
UCK1Cytidine0.7 × 10⁴ATP/GTP
UCK2Uridine~5 × 10⁴ATP/GTP
UCK2Cytidine~5 × 10⁴ATP/GTP
UCKL-1Uridine1.2 × 10⁴ATP/GTP
UCKL-1Cytidine0.7 × 10⁴ATP/GTP

Data compiled from enzymatic assays .

Crystal Structure

The crystal structure of UCK1 (PDB: 2UVQ) reveals a globular fold with a conserved ATP/GTP-binding site . Key features include:

  • Active site: Binds uridine/cytidine via hydrogen bonds and hydrophobic interactions.

  • Phosphate donor binding: ATP/GTP occupies a distinct pocket adjacent to the substrate .

Comparison with UCK2 and UCKL-1

FeatureUCK1UCK2UCKL-1
Tissue ExpressionUbiquitousTumor/placentalUbiquitous (high in tumors)
Catalytic EfficiencyModerateHighSimilar to UCK1
FunctionGeneral salvageTumor-specificTumor growth/metastasis

Derived from tissue expression data and enzymatic studies .

Tissue Distribution

UCK1 exhibits nuclear expression in most human tissues, including the brain, liver, and pancreas . Its ubiquitous presence underscores its role in maintaining nucleotide pools for DNA/RNA synthesis.

Gene and Isoforms

  • Gene location: 9q34.13 .

  • Splice variants: Alternative splicing generates distinct isoforms, though functional differences remain uncharacterized .

Tumor Metabolism

UCK1 contributes to the pyrimidine salvage pathway, which is critical for cancer cell proliferation. In pancreatic ductal adenocarcinoma (PDA), uridine-derived ribose fuels glucose-restricted tumors via UPP1-mediated catabolism . While UCK1 itself is not the focus of this pathway, its upstream role in generating UMP/CMP positions it as a potential regulator of nucleotide availability in cancer.

Therapeutic Implications

  • Drug activation: Phosphorylates anticancer analogs (e.g., 5-fluorouridine), making it a target for modulating drug efficacy .

  • Tumor progression: UCKL-1, a homolog, promotes tumor growth and metastasis, suggesting shared pathways with UCK1 .

STRING-DB Interaction Network

ProteinInteraction ScoreFunctional Relevance
UPRT0.999Uracil phosphoribosyltransferase (salvage pathway)
UPP20.982Uridine phosphorylase (nucleoside catabolism)
UCK20.980Tumor-associated kinase
CDA0.977Cytidine deaminase (nucleotide metabolism)

Data from STRING interaction database .

ELISA Kits for Detection

  • MyBioSource Kit (MBS9343682): Quantifies UCK1 in biological samples, enabling studies on its expression in disease states .

  • Recombinant UCK1 (Cusabio): Used for structural and functional studies .

Product Specs

Introduction
UCK1, a uridine-cytidine kinase, plays a crucial role in the phosphorylation of uridine and cytidine to their respective monophosphates, uridine monophosphate (UMP) and cytidine monophosphate (CMP). It exhibits specificity for uridine and cytidine, refraining from phosphorylating deoxyribonucleosides or purine ribonucleosides. Notably, UCK1 also demonstrates activity towards uridine and cytidine analogs, utilizing both ATP and GTP as phosphate donors.
Description
Recombinant human UCK1, expressed in E. coli, is a non-glycosylated polypeptide chain with a molecular weight of 17.5 kDa. It consists of 152 amino acids, spanning from position 143 to 273a.a. The protein includes a 21 amino acid His-tag fused at the N-terminus and is purified using proprietary chromatographic techniques.
Physical Appearance
The product is a sterile, colorless solution that has been filtered for sterility.
Formulation
The UCK1 solution is provided at a concentration of 1 mg/ml and contains 20 mM Tris-HCl buffer (pH 8.0), 10% glycerol, and 0.4 M urea.
Stability
For short-term storage (2-4 weeks), the product should be kept at 4°C. For extended storage, it is recommended to freeze the product at -20°C. Adding a carrier protein (0.1% HSA or BSA) is advisable for long-term storage. It's important to avoid repeated freeze-thaw cycles to maintain product integrity.
Purity
The purity of the UCK1 protein is determined to be greater than 80.0% using SDS-PAGE analysis.
Synonyms
Uridine-cytidine kinase 1, UCK 1, Cytidine monophosphokinase 1, UCK1 Uridine monophosphokinase 1, URK1, FLJ12255, RP11-334J6.5, Uridine-cytidine kinase 1 isoform a.
Source
Escherichia Coli.
Amino Acid Sequence
MGSSHHHHHH SSGLVPRGSH MFYSQEIRDM FHLRLFVDTD SDVRLSRRVL RDVRRGRDLE QILTQYTTFV KPAFEEFCLP TKKYADVIIP RGVDNMVAIN LIVQHIQDIL NGDICKWHRG GSNGRSYKRT FSEPGDHPGM LTSGKRSHLE SS.

Q&A

What is UCK1 and what are its primary functions?

UCK1 (Uridine-Cytidine Kinase 1) is a protein-coding gene that encodes an enzyme involved in nucleotide metabolism. It primarily catalyzes the phosphorylation of uridine and cytidine to uridine monophosphate (UMP) and cytidine monophosphate (CMP), respectively . This enzyme plays a crucial role in the pyrimidine salvage pathway, which recycles nucleosides for nucleotide synthesis without requiring de novo synthesis. UCK1 does not phosphorylate deoxyribonucleosides or purine ribonucleosides, making it specific for pyrimidine ribonucleosides . This selective activity positions UCK1 as a key regulator in pyrimidine nucleotide homeostasis and cellular metabolism.

Where is UCK1 located in the cell and in the genome?

UCK1 protein is predominantly localized in the cytosol of cells . This cytoplasmic localization is consistent with its role in nucleoside metabolism, which primarily occurs outside the nucleus. At the genomic level, the human UCK1 gene is located on chromosome 9q34.13 . This genomic position has implications for understanding the regulation of UCK1 expression and potential linkage to other genes or disease associations in this chromosomal region.

What is the molecular structure and biochemical properties of UCK1?

UCK1 is a protein with a molecular weight of approximately 32,275 Da . The protein structure consists of domains characteristic of the uridine kinase family, including phosphoribulokinase/uridine kinase domains and P-loop containing nucleoside triphosphate hydrolase regions . UCK1 utilizes ATP or GTP as phosphate donors for its kinase activity . The protein can exist in multiple isoforms due to alternative splicing of the UCK1 gene transcript . Structurally, UCK1 has been analyzed through both experimental approaches and computational predictions, with models available through resources like AlphaFold .

What are the established methods for studying UCK1 activity in vitro?

For in vitro analysis of UCK1 activity, researchers commonly employ enzyme kinetics assays using purified recombinant UCK1 protein with radiolabeled or fluorescently labeled nucleoside substrates. A standard approach involves incubating UCK1 with uridine or cytidine in the presence of ATP or GTP and appropriate buffers, followed by quantification of phosphorylated products using HPLC, mass spectrometry, or radiometric detection. When establishing such assays, critical parameters include pH optimization (typically around physiological pH 7.4), temperature (usually 37°C for human enzymes), and appropriate concentrations of divalent cations like Mg²⁺, which are essential cofactors for kinase activity.

Alternative approaches include coupled enzyme assays where UCK1 activity is linked to detectable reactions, such as monitoring ADP production through pyruvate kinase and lactate dehydrogenase with NADH consumption as the readout. These methods allow real-time continuous monitoring of enzyme activity rather than endpoint measurements.

How can UCK1 expression be manipulated in cellular models?

Several approaches exist for manipulating UCK1 expression in cellular models:

  • CRISPR/Cas9 knockout systems: As evidenced by the available UCK1 knockout HEK-293T cell line, CRISPR/Cas9 technology can be used to create specific deletions (like the 10 bp and 1 bp deletions in exon 1) to generate complete loss of function models . When designing guide RNAs, targeting early exons (particularly exon 1) maximizes the likelihood of functional disruption.

  • RNA interference: siRNA or shRNA approaches offer transient or stable knockdown options, respectively. For UCK1, designing siRNAs targeting conserved regions across transcript variants ensures comprehensive knockdown of all isoforms.

  • Overexpression systems: Utilizing vectors containing UCK1 cDNA under strong promoters (CMV, EF1α) for transient or stable expression. Adding epitope tags (FLAG, HA) or fluorescent protein fusions enables easier detection and purification, though care must be taken to verify that tags don't interfere with enzyme function.

  • Inducible expression systems: Tet-On/Tet-Off systems allow for controlled expression timing, which is particularly valuable for studying dose-dependent effects of UCK1 on nucleoside metabolism.

When selecting cell models, consider endogenous UCK1 expression levels, as they vary across cell types and may influence interpretation of manipulation results.

What are the recommended methods for detecting UCK1 protein and activity in tissue samples?

For detecting UCK1 in tissue samples, multiple complementary approaches are recommended:

Protein Detection Methods:

  • Immunohistochemistry (IHC) and immunofluorescence for spatial localization within tissues

  • Western blotting for semi-quantitative analysis of expression levels

  • ELISA using validated UCK1-specific antibodies for quantitative measurement

  • Mass spectrometry-based proteomics for unbiased detection and quantification

Activity Assays in Tissue Extracts:

  • Prepare tissue homogenates in non-denaturing buffers containing protease inhibitors

  • Clear cellular debris by centrifugation to obtain cytosolic fractions

  • Incubate extracts with radiolabeled substrates (typically ³H-uridine or ¹⁴C-cytidine)

  • Separate phosphorylated products using thin-layer chromatography or HPLC

  • Quantify product formation relative to protein concentration

When analyzing patient samples, consider including normal adjacent tissue as controls and normalizing activity to total protein content. For preserving enzyme activity in tissue samples, rapid freezing in liquid nitrogen immediately after collection is crucial, as UCK1 activity can diminish with delayed processing or improper storage.

How is UCK1 involved in cancer biology and potential therapeutic strategies?

UCK1 has emerged as a significant factor in cancer biology due to its role in nucleoside metabolism, which is often dysregulated in rapidly proliferating cancer cells. Cancer cells typically have elevated nucleotide demands to support accelerated DNA replication and RNA synthesis. Consequently, altered UCK1 expression or activity may contribute to the metabolic reprogramming observed in various malignancies.

The therapeutic relevance of UCK1 stems primarily from its ability to phosphorylate nucleoside analogs used in cancer chemotherapy. Many pyrimidine-based antimetabolites require initial phosphorylation by nucleoside kinases like UCK1 to generate their active metabolites. This activation step is crucial for their cytotoxic effects. Therefore, variations in UCK1 expression or activity across different tumors may partially explain differential responses to nucleoside analog therapies.

Research approaches examining UCK1 in cancer contexts include:

  • Correlation studies between UCK1 expression levels and patient outcomes in various cancer types

  • Functional studies examining how UCK1 knockdown or overexpression affects cancer cell proliferation, survival, and metastatic potential

  • Combination therapy investigations to determine if UCK1 modulators can sensitize resistant tumors to nucleoside analog treatments

When designing such studies, researchers should account for the potential compensatory activity of related enzymes, particularly UCK2, which shares substrate specificity with UCK1.

What role might UCK1 play in viral infections and antiviral therapies?

UCK1's ability to phosphorylate both natural nucleosides and their analogs positions it as an important enzyme in antiviral strategies. Several nucleoside analog drugs targeting viral RNA or DNA polymerases require initial phosphorylation by host kinases like UCK1 to be converted to their active forms.

Of particular interest is the observation that ribavirin, a broad-spectrum antiviral agent, is a potential substrate for UCK1 . This suggests that variations in UCK1 activity might influence the efficacy of ribavirin-based therapies for conditions like hepatitis C or other viral infections. The phosphorylation of ribavirin by UCK1 represents the rate-limiting step in its activation to ribavirin monophosphate (RMP), which can subsequently be converted to the triphosphate form that interferes with viral RNA synthesis.

For researchers investigating UCK1's role in antiviral therapies, key considerations include:

  • Determining the kinetic parameters of UCK1-mediated phosphorylation for specific antiviral nucleoside analogs

  • Examining whether viral infections modulate UCK1 expression or activity as part of host response or viral evasion strategies

  • Investigating genetic polymorphisms in UCK1 that might affect enzyme activity and, consequently, patient responses to nucleoside analog antivirals

Studies should incorporate both in vitro enzyme assays and cellular models of viral infection to comprehensively assess UCK1's contribution to antiviral efficacy.

How do genetic variations in UCK1 affect enzyme function and disease susceptibility?

Genetic variations in UCK1 may have significant implications for enzyme function and, consequently, disease susceptibility or treatment outcomes. While the search results don't provide specific information about common UCK1 polymorphisms, understanding the potential impact of genetic variations is crucial for personalized medicine approaches.

Several types of genetic variations could affect UCK1 function:

  • Coding region variants: Missense mutations may alter the enzyme's catalytic efficiency, substrate specificity, or stability. Of particular concern would be variants affecting the ATP-binding domain or substrate recognition sites.

  • Regulatory region variants: Polymorphisms in promoter regions could influence UCK1 expression levels, potentially affecting the cell's capacity to recycle pyrimidine nucleosides or activate nucleoside analog drugs.

  • Splicing variants: Alterations at splice sites might lead to alternative UCK1 isoforms with modified functional properties.

Research approaches to investigate UCK1 genetic variations include:

  • Genotype-phenotype correlation studies in diverse patient populations

  • Functional characterization of recombinant UCK1 variants in vitro

  • Computational modeling to predict the impact of amino acid substitutions on protein structure and function

  • CRISPR-mediated introduction of specific variants into cellular models to assess their functional consequences

When designing such studies, researchers should consider the potential compensatory mechanisms that might mask the effects of UCK1 variants, such as the activity of related enzymes or alternative metabolic pathways.

How does UCK1 interact with other enzymes in nucleotide metabolism pathways?

UCK1 functions within a complex network of enzymes involved in nucleotide metabolism. Understanding these interactions is crucial for comprehending cellular nucleotide homeostasis and the potential consequences of UCK1 dysregulation.

Key interactions and pathway connections include:

  • Relationship with de novo pyrimidine synthesis: UCK1's salvage pathway activity complements the de novo synthesis pathway. Research suggests reciprocal regulation between these pathways, with increased salvage activity potentially downregulating de novo synthesis enzymes to maintain nucleotide pool balance.

  • Coordination with UCK2: Both UCK1 and UCK2 phosphorylate uridine and cytidine, but with different kinetic properties and tissue distribution patterns. Investigating their relative contributions in different cellular contexts and potential compensatory mechanisms is essential for understanding the consequences of UCK1 manipulation.

  • Downstream nucleotide kinases: After UCK1 generates UMP or CMP, further phosphorylation by nucleoside monophosphate kinases and nucleoside diphosphate kinases is required to produce the triphosphate forms used in RNA synthesis. The coordination between these sequential enzymatic steps may involve regulatory feedback mechanisms.

  • Metabolic sensing and regulation: UCK1 activity may be influenced by cellular energy status through interactions with metabolic sensors like AMPK or mTOR pathways.

Research approaches to investigate these interactions include:

  • Metabolic flux analysis using isotope-labeled nucleosides

  • Protein-protein interaction studies using co-immunoprecipitation or proximity ligation assays

  • Systems biology modeling of nucleotide metabolism incorporating enzyme kinetics data

  • Multi-omics approaches combining transcriptomics, proteomics, and metabolomics

What are the regulatory mechanisms controlling UCK1 expression and activity?

Understanding the regulation of UCK1 at both transcriptional and post-translational levels is crucial for comprehending how cells adjust nucleoside salvage activity in response to changing metabolic demands. While the search results don't provide specific information about UCK1 regulation, several potential regulatory mechanisms warrant investigation:

Transcriptional Regulation:

  • Cell cycle-dependent expression patterns, particularly in relation to S-phase when nucleotide demand increases

  • Tissue-specific transcription factors that might explain differential expression across tissues

  • Potential regulation by nutrient-sensing pathways that coordinate nucleotide synthesis with cellular metabolic status

Post-translational Modifications:

  • Phosphorylation sites that might modulate enzyme activity or stability

  • Ubiquitination patterns affecting protein turnover rates

  • Potential allosteric regulation by nucleotides or metabolites

Structural Regulation:

  • Formation of homo or heteromultimeric complexes affecting enzyme kinetics

  • Subcellular localization changes in response to cellular stress or metabolic alterations

Experimental approaches to investigate these regulatory mechanisms include:

  • Promoter analysis using reporter assays to identify key regulatory elements

  • Chromatin immunoprecipitation to identify transcription factors binding to the UCK1 promoter

  • Mass spectrometry-based approaches to identify post-translational modifications

  • Proximity labeling techniques to map the UCK1 protein interaction network

Researchers should design time-course experiments to capture dynamic regulation of UCK1 under different cellular conditions, such as nutrient deprivation, cell cycle progression, or cellular stress responses.

How can advanced structural biology techniques contribute to understanding UCK1 function and developing specific inhibitors?

Advanced structural biology approaches offer powerful tools for elucidating UCK1 function at the molecular level and developing selective modulators. The search results indicate that both experimental structures from the Protein Data Bank and computational models from AlphaFold are available for UCK1 .

Key structural biology approaches and their applications for UCK1 research include:

X-ray Crystallography and Cryo-EM:

  • Determination of UCK1 structures in complex with substrates, products, and potential inhibitors

  • Identification of conformational changes associated with catalysis

  • Visualization of binding sites for rational drug design

NMR Spectroscopy:

  • Characterization of protein dynamics relevant to substrate binding and catalysis

  • Identification of allosteric sites that might not be evident in static structures

  • Fragment-based screening to identify novel binding molecules

Computational Approaches:

  • Molecular dynamics simulations to understand protein flexibility and substrate binding pathways

  • Virtual screening of compound libraries to identify potential UCK1-specific inhibitors

  • Structure-based design of selective inhibitors that distinguish UCK1 from related kinases

For developing UCK1-specific inhibitors, researchers should focus on structural features that differentiate UCK1 from UCK2 and other nucleoside kinases. This may involve targeting non-conserved residues near the active site or exploiting unique allosteric sites.

When conducting structure-based drug design, consider:

  • The influence of water molecules in the binding site

  • Potential induced-fit conformational changes upon ligand binding

  • The energetic contributions of different binding site interactions

  • The physicochemical properties required for cellular permeability and target engagement

An integrated approach combining structural biology with medicinal chemistry and cellular validation will be most effective for translating structural insights into functional UCK1 modulators.

What are the optimal cell models and conditions for studying UCK1 function?

Selecting appropriate cellular models and experimental conditions is crucial for meaningful UCK1 research. Based on the search results and established research practices, consider the following recommendations:

Cell Line Selection:

  • HEK293T cells have been successfully used for UCK1 knockout studies and are well-suited for initial characterization due to their high transfection efficiency

  • Consider cell lines with different baseline UCK1 expression levels to study dose-dependent effects

  • Cancer cell lines with altered nucleotide metabolism may provide insights into the role of UCK1 in malignancy

  • Primary cells more closely reflect physiological conditions but present challenges for genetic manipulation

Culture Conditions:

  • Standard conditions include DMEM with high glucose supplemented with 10% FBS

  • For nucleoside metabolism studies, consider using dialyzed serum to control the nucleoside background

  • Monitor cell density carefully, as contact inhibition can affect nucleotide metabolism

  • When performing nucleoside salvage assays, ensure media composition does not contain the nucleosides being studied

Experimental Design Considerations:

  • Include appropriate controls when manipulating UCK1 expression:

    • Wild-type parental cells as baseline controls

    • Empty vector controls for overexpression studies

    • Non-targeting siRNA/shRNA for knockdown experiments

    • Rescue experiments by reintroducing wild-type UCK1 in knockout models

  • Time course experiments are essential for capturing the dynamic effects of UCK1 modulation on nucleotide pools

  • Complement genetic approaches with pharmacological inhibition when available

When establishing UCK1 knockout models, validate the knockout at both the genomic level (sequencing) and protein level (Western blot) to confirm complete loss of function .

What are the challenges in distinguishing UCK1 from UCK2 activity in experimental settings?

Distinguishing between UCK1 and UCK2 activities presents significant challenges due to their overlapping substrate specificities and functions. Both enzymes phosphorylate uridine and cytidine, although with different kinetic parameters. Addressing this challenge is crucial for accurately attributing observed effects to the specific enzyme.

Challenges and Solutions:

  • Substrate specificity overlap:

    • While both enzymes phosphorylate uridine and cytidine, UCK2 typically exhibits higher catalytic efficiency

    • Investigate potential differential activity toward nucleoside analogs that might be preferentially phosphorylated by one enzyme over the other

  • Expression pattern differences:

    • Analyze tissue-specific expression patterns, as UCK1 and UCK2 may have different expression profiles across tissues

    • In experimental systems, quantify the relative expression levels of both enzymes to understand their potential contributions

  • Genetic approaches:

    • Use specific knockout or knockdown models for each enzyme individually and in combination

    • The UCK1 knockout cell line mentioned in the search results provides a valuable tool for distinguishing UCK1-specific functions

  • Biochemical discrimination:

    • Develop enzyme-specific antibodies for immunoprecipitation followed by activity assays

    • Consider using selective inhibitors if available, although highly selective UCK1 or UCK2 inhibitors are currently limited

  • Kinetic analysis:

    • Compare reaction kinetics with various substrates to identify conditions where one enzyme's contribution predominates

    • Measure activity across a range of substrate concentrations to exploit potential differences in Km values

When designing experiments to distinguish UCK1 and UCK2 activities, consider implementing multiple complementary approaches rather than relying on a single method.

What are the best strategies for analyzing metabolic flux through UCK1-dependent pathways?

Metabolic flux analysis provides crucial insights into how UCK1 influences nucleoside metabolism dynamics. Several sophisticated approaches can be applied to track the flow of metabolites through UCK1-dependent pathways:

Isotope Labeling Approaches:

  • ¹³C or ¹⁵N-labeled nucleoside tracing: Supply cells with isotopically labeled uridine or cytidine and track the incorporation of labeled atoms into downstream metabolites using mass spectrometry

  • Pulse-chase experiments: Expose cells to labeled substrates for a defined period (pulse), then switch to unlabeled media (chase) to follow the metabolic fate of the labeled compounds over time

  • Positional isotopomer analysis: Use nucleosides labeled at specific positions to distinguish between different metabolic routes

Analytical Methods:

  • LC-MS/MS: Provides high sensitivity for detecting and quantifying nucleosides and their phosphorylated derivatives

  • NMR spectroscopy: Offers detailed structural information about metabolite flux, particularly valuable for tracking position-specific isotope incorporation

  • Capillary electrophoresis-MS: Useful for separating highly polar nucleotides and their derivatives

Experimental Designs:

  • Compare flux patterns between wild-type and UCK1-manipulated cells

  • Analyze flux under different physiological conditions (proliferation, differentiation, stress)

  • Investigate compensatory flux changes through parallel pathways when UCK1 is inhibited

Data Analysis Approaches:

  • Metabolic flux analysis (MFA): Mathematical modeling using isotope labeling patterns to calculate flux rates

  • Flux balance analysis (FBA): Computational approach using stoichiometric constraints to predict optimal flux distributions

  • Kinetic modeling: Incorporation of enzyme kinetic parameters to predict dynamic responses to perturbations

When designing flux studies, researchers should carefully consider sampling timepoints based on the expected turnover rates of the metabolites of interest, as nucleotide metabolism can be rapid in actively proliferating cells.

How might UCK1 function be affected by cellular stress conditions?

Cellular stress conditions likely influence UCK1 expression and activity, with potential implications for nucleotide metabolism adaptation during stress responses. While specific data on UCK1's response to stress is limited in the search results, several hypotheses and research directions are worth investigating:

Oxidative Stress:

  • Oxidative stress may directly affect UCK1 through oxidation of critical cysteine residues

  • Alterations in redox status could influence UCK1's interaction with substrates or cofactors

  • Research Question: Does oxidative stress alter the kinetic properties of UCK1, and what are the consequences for pyrimidine salvage?

Nutrient Stress:

  • Nucleoside salvage pathways may become more critical during nutrient limitation when de novo synthesis is energetically costly

  • UCK1 regulation might be linked to nutrient-sensing pathways like AMPK or mTOR

  • Research Question: Is UCK1 expression or activity upregulated during nutrient deprivation to maximize nucleoside recycling?

Hypoxia:

  • Oxygen limitation affects numerous metabolic pathways, potentially including nucleotide metabolism

  • Research Question: Does hypoxia alter the balance between de novo pyrimidine synthesis and salvage pathways involving UCK1?

Genotoxic Stress:

  • DNA damage increases nucleotide demand for repair processes

  • Research Question: Is UCK1 activity modulated as part of the cellular response to genotoxic agents to support nucleotide pool maintenance?

Experimental approaches to investigate these questions include:

  • Transcriptomic and proteomic profiling of UCK1 under various stress conditions

  • Activity assays to determine if stress conditions alter enzyme kinetics

  • Metabolomic analysis to assess the impact of stress on nucleoside and nucleotide pools

  • Cell survival studies comparing UCK1-proficient and UCK1-deficient cells under stress conditions

Researchers should design time-course experiments to distinguish between acute and adaptive responses to stress conditions.

What are the implications of UCK1 in cellular differentiation and development?

The role of UCK1 in cellular differentiation and development represents an underexplored area with significant potential implications. While the search results don't directly address this aspect, nucleotide metabolism dynamics are known to change during differentiation processes, suggesting potential developmental roles for nucleoside salvage enzymes like UCK1.

Research Areas to Explore:

  • Developmental Expression Patterns:

    • Characterize UCK1 expression across different developmental stages and tissues

    • Investigate whether UCK1 expression changes during lineage commitment in stem cell models

    • Research Question: Are there developmentally regulated isoforms of UCK1 with distinct properties?

  • Functional Requirements in Development:

    • Determine if UCK1 knockout affects embryonic development using model organisms

    • Investigate tissue-specific requirements for UCK1 during organogenesis

    • Research Question: Are there developmental processes particularly dependent on nucleoside salvage pathways?

  • Stem Cell Biology:

    • Compare UCK1 expression and activity between pluripotent cells and differentiated derivatives

    • Determine if UCK1 inhibition affects differentiation capacity or lineage choice

    • Research Question: Does metabolic rewiring during differentiation involve changes in UCK1-dependent salvage pathways?

  • Regenerative Processes:

    • Investigate UCK1 regulation during tissue regeneration models

    • Examine if UCK1 activity correlates with proliferative capacity in regenerating tissues

    • Research Question: Is UCK1 upregulated during regenerative processes with high nucleotide demands?

Experimental approaches should include:

  • Conditional knockout models to bypass potential embryonic lethality

  • In vitro differentiation systems with temporal analysis of UCK1 expression and activity

  • Single-cell approaches to capture heterogeneity in UCK1 expression during differentiation processes

Researchers should consider potential compensatory mechanisms, particularly UCK2 activity, when interpreting developmental phenotypes associated with UCK1 manipulation.

How can systems biology approaches enhance our understanding of UCK1 in the broader context of cellular metabolism?

Systems biology approaches offer powerful frameworks for understanding UCK1's role within the complex network of cellular metabolism. By integrating multiple data types and computational modeling, researchers can gain comprehensive insights that would be difficult to achieve through reductionist approaches alone.

Key Systems Biology Approaches for UCK1 Research:

  • Multi-omics Integration:

    • Combine transcriptomics, proteomics, and metabolomics data to create comprehensive maps of UCK1-related pathways

    • Identify potential regulatory relationships not apparent from single-omics approaches

    • Research Question: How do perturbations in UCK1 expression propagate through the broader metabolic network?

  • Genome-scale Metabolic Modeling:

    • Incorporate UCK1 kinetics into genome-scale metabolic models

    • Perform in silico knockouts to predict system-wide consequences of UCK1 deficiency

    • Research Question: What are the predicted metabolic vulnerabilities in UCK1-deficient cells?

  • Network Analysis:

    • Map the position of UCK1 within nucleotide metabolism networks

    • Identify potential synthetic lethal interactions with other metabolic enzymes

    • Research Question: Which network properties make certain pathways more sensitive to UCK1 inhibition?

  • Dynamic Modeling:

    • Develop kinetic models of nucleoside salvage pathways including UCK1

    • Simulate temporal responses to perturbations in substrate availability or enzyme activity

    • Research Question: How do feedback mechanisms involving UCK1 contribute to nucleotide homeostasis?

  • Machine Learning Applications:

    • Apply machine learning to predict conditions where UCK1 activity becomes limiting

    • Identify potential biomarkers of altered UCK1 function from multi-omics data

    • Research Question: Can machine learning identify previously unrecognized relationships between UCK1 and other cellular processes?

Implementation strategies should include:

  • Careful experimental design with appropriate time-resolved measurements

  • Validation of computational predictions through targeted experiments

  • Consideration of cell type-specific metabolic contexts

  • Integration of UCK1-focused studies with broader metabolic profiling

By adopting systems biology approaches, researchers can position UCK1 studies within a holistic understanding of cellular metabolism, potentially revealing unexpected connections and therapeutic opportunities.

Product Science Overview

Structure and Function

UCK1 is a protein-coding gene that encodes a 277 amino-acid protein with a predicted molecular mass of approximately 31 kDa . The enzyme is universally expressed in healthy tissues and is involved in the phosphorylation of uridine and cytidine using ATP or GTP as phosphate donors . This phosphorylation is the first step in the pyrimidine salvage pathway and is considered rate-limiting .

Isoforms and Homology

There are two primary human uridine-cytidine kinases: UCK1 and UCK2. UCK1 is expressed in a wide range of tissues, while UCK2 is more restricted, being primarily found in the human placenta and various tumor cells . UCK1 and UCK2 share 72% sequence homology .

Recombinant UCK1

Recombinant UCK1 is produced through the expression of the UCK1 gene in a host organism, typically bacteria or yeast, to obtain large quantities of the enzyme for research and therapeutic purposes. This recombinant form retains the functional properties of the native enzyme, making it valuable for biochemical studies and potential therapeutic applications.

Role in Disease and Therapeutic Potential

UCK1 has been implicated in various diseases, including cancer. The enzyme’s activity is essential for the proliferation of rapidly dividing cells, such as tumor cells, which rely on the pyrimidine salvage pathway for nucleotide synthesis . Inhibiting UCK1 activity has been proposed as a potential therapeutic strategy for targeting cancer cells .

Research and Applications

Research on UCK1 has focused on understanding its role in nucleotide metabolism and its potential as a therapeutic target. Studies have shown that UCK1 can phosphorylate various uridine and cytidine analogs, which are used in chemotherapy . This makes UCK1 a critical enzyme for the activation of these analogs into their active forms.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2024 Thebiotek. All Rights Reserved.